You are here

Cong Zhu


Zhu C, Byers KJRP, McCord RP, et al. High-resolution DNA-binding specificity analysis of yeast transcription factors. Genome Res. 2009;19:556–566.

Zhu C, Smith T, McNulty J, et al. Evaluation and application of modularly assembled zinc-finger nucleases in zebrafish. Development. 2011;138:4555–4564.

Kim E, Ilic N, Shrestha Y, et al. Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles. Cancer Discov. 2016;6(7):714–726.

Cong Zhu, Ph.D.

Cong Zhu is a research scientist II in the Cancer Program at the Broad Institute of MIT and Harvard, working under the direction of Chris Mader. He participates in research and development of novel ways to use the PRISM assay for drug target discovery and validation.

Prior to joining the Broad Institute in 2012, Zhu conducted his postdoctoral research at UMass Medical School and Brigham & Women's Hospital in Boston.

Zhu holds a Ph.D. in molecular biology and biochemistry from the University of Kentucky and a B.S. from Nankai University.

Contact Cong Zhu at

February 2017